Deborah Studer

443 total citations
11 papers, 357 citations indexed

About

Deborah Studer is a scholar working on Molecular Biology, Rheumatology and Hematology. According to data from OpenAlex, Deborah Studer has authored 11 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 3 papers in Rheumatology and 2 papers in Hematology. Recurrent topics in Deborah Studer's work include Protein Degradation and Inhibitors (4 papers), Osteoarthritis Treatment and Mechanisms (3 papers) and Clinical practice guidelines implementation (1 paper). Deborah Studer is often cited by papers focused on Protein Degradation and Inhibitors (4 papers), Osteoarthritis Treatment and Mechanisms (3 papers) and Clinical practice guidelines implementation (1 paper). Deborah Studer collaborates with scholars based in Canada, Switzerland and Mexico. Deborah Studer's co-authors include Marcy Zenobi‐Wong, Katharina Maniura‐Weber, Ece Öztürk, Carola Millán, Wolfram Jochum, Martin Ehrbar, Kristina D. Rinker, Dean Gilham, Jan O. Johansson and Sylwia Wasiak and has published in prestigious journals such as Journal of the American College of Cardiology, Small and European Heart Journal.

In The Last Decade

Deborah Studer

10 papers receiving 348 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Deborah Studer Canada 7 156 148 67 53 46 11 357
Margaret E. Cooke United States 7 153 1.0× 151 1.0× 123 1.8× 60 1.1× 50 1.1× 10 463
Shuiliang Shi United States 10 216 1.4× 117 0.8× 86 1.3× 34 0.6× 51 1.1× 18 347
Elise Duval France 8 231 1.5× 98 0.7× 86 1.3× 80 1.5× 53 1.2× 10 368
Hiraku Motomura Japan 10 144 0.9× 129 0.9× 114 1.7× 76 1.4× 52 1.1× 14 410
Shanxing Zhang China 12 181 1.2× 174 1.2× 119 1.8× 64 1.2× 31 0.7× 22 465
Sharon Ansboro Ireland 8 195 1.3× 149 1.0× 75 1.1× 140 2.6× 55 1.2× 9 461
Karolina Kania United Kingdom 6 209 1.3× 163 1.1× 94 1.4× 109 2.1× 39 0.8× 8 412
Helga Joos Germany 10 209 1.3× 55 0.4× 101 1.5× 40 0.8× 43 0.9× 14 325
Andrea Lolli Netherlands 12 208 1.3× 185 1.3× 125 1.9× 70 1.3× 52 1.1× 20 474
Theoni Katopodi United Kingdom 5 236 1.5× 77 0.5× 94 1.4× 121 2.3× 105 2.3× 6 353

Countries citing papers authored by Deborah Studer

Since Specialization
Citations

This map shows the geographic impact of Deborah Studer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah Studer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah Studer more than expected).

Fields of papers citing papers by Deborah Studer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah Studer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah Studer. The network helps show where Deborah Studer may publish in the future.

Co-authorship network of co-authors of Deborah Studer

This figure shows the co-authorship network connecting the top 25 collaborators of Deborah Studer. A scholar is included among the top collaborators of Deborah Studer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deborah Studer. Deborah Studer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Wasiak, Sylwia, Li Fu, Dean Gilham, et al.. (2023). The BET inhibitor apabetalone decreases neuroendothelial proinflammatory activationin vitroand in a mouse model of systemic inflammation. Translational Neuroscience. 14(1). 20220332–20220332. 1 indexed citations
2.
Shepherd, Robert D., Deborah Studer, Amy Bromley, et al.. (2021). Linking Aortic Mechanical Properties, Gene Expression and Microstructure: A New Perspective on Regional Weakening in Abdominal Aortic Aneurysms. Frontiers in Cardiovascular Medicine. 8. 631790–631790. 7 indexed citations
3.
4.
Tsujikawa, Laura, Li Fu, Brooke D. Rakai, et al.. (2019). APABETALONE, AN EPIGENETIC BET INHIBITOR IN A PHASE 3 TRIAL, INHIBITS VASCULAR INFLAMMATION AND CELLULAR ADHESION LEADING TO BENEFICIAL OUTCOMES IN CVD PATIENTS. Journal of the American College of Cardiology. 73(9). 2063–2063. 1 indexed citations
5.
Tsujikawa, Laura, Li Fu, Christopher Halliday, et al.. (2019). Apabetalone (RVX-208) reduces vascular inflammation in vitro and in CVD patients by a BET-dependent epigenetic mechanism. Clinical Epigenetics. 11(1). 102–102. 90 indexed citations
6.
Kulikowski, Ewelina, Laura Tsujikawa, Dean Gilham, et al.. (2019). P5509Apabetalone (RVX-208) inhibits key drivers of vascular inflammation, calcification, and plaque vulnerability through a BET-dependent epigenetic mechanism. European Heart Journal. 40(Supplement_1). 1 indexed citations
7.
Studer, Deborah, Emma Cavalli, Gian M. Salzmann, et al.. (2016). Human chondroprogenitors in alginate-collagen hybrid scaffolds produce stable cartilagein vivo. Journal of Tissue Engineering and Regenerative Medicine. 11(11). 3014–3026. 24 indexed citations
8.
Studer, Deborah, et al.. (2012). Ribosomal Protein L13a as a Reference Gene for Human Bone Marrow-Derived Mesenchymal Stromal Cells During Expansion, Adipo-, Chondro-, and Osteogenesis. Tissue Engineering Part C Methods. 18(10). 761–771. 46 indexed citations
9.
Studer, Deborah, et al.. (2012). Molecular and biophysical mechanisms regulating hypertrophic differentiation in chondrocytes and mesenchymal stem cells. European Cells and Materials. 24. 118–135. 167 indexed citations
10.
Studer, Deborah, Raghavendra Palankar, Matthieu F. Bédard, Mathias Winterhalter, & Sebastian Springer. (2010). Retrieval of a Metabolite from Cells with Polyelectrolyte Microcapsules. Small. 6(21). 2412–2419. 9 indexed citations
11.
Alberati, Daniela, Simona Ceccarelli, Synèse Jolidon, et al.. (2006). Design and synthesis of 4-substituted-8-(2-phenyl-cyclohexyl)-2,8-diaza-spiro[4.5]decan-1-one as a novel class of GlyT1 inhibitors: Achieving selectivity against the μ opioid and nociceptin/orphanin FQ peptide (NOP) receptors. Bioorganic & Medicinal Chemistry Letters. 16(16). 4305–4310. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Margaret E. Cooke Breakdown of academic impact, for papers by Shuiliang Shi Breakdown of academic impact, for papers by Elise Duval Breakdown of academic impact, for papers by Hiraku Motomura Breakdown of academic impact, for papers by Shanxing Zhang Breakdown of academic impact, for papers by Sharon Ansboro Breakdown of academic impact, for papers by Karolina Kania Breakdown of academic impact, for papers by Helga Joos Breakdown of academic impact, for papers by Andrea Lolli Breakdown of academic impact, for papers by Theoni Katopodi
Rankless by CCL
2026